Delivering Cost-Effective, Robust Processes and Methods Quickly and Efficiently

As the underlying technology for making antibodies, therapeutic proteins, and vaccines matures, speed and efficiency become more important.  This conference will focus on recent developments (particularly new, "disruptive" technologies) that will be key to accelerating the pace and productivity of biopharmaceutical development.  If you are working on the development and manufacture of biopharmaceuticals such as antibodies, vaccines or therapeutic proteins, you should attend to learn how you can improve your productivity.  

Keynote Speakers:

• John Carpenter, Professor of Pharmaceutical Biotechnology, Co-Director, Center for Pharmaceutical Biology, University of Colorado Denver. "Protein Aggregation: Causes, Consequences, Control and Challenges."
• Rob Garnick, Senior Vice President, Regulatory, Quality and Compliance, Genentech. "Recent Developments in Biosimilars."
• Janice Reichert, Senior Research Fellow, Tufts Center for the Study of Drug Development, Boston, Massachusetts USA. "Development Trends for Biotherapeutics."

Organizing Committee
Program
Travel and Accommodations
Sponsors